162 related articles for article (PubMed ID: 37403840)
41. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
42. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
[TBL] [Abstract][Full Text] [Related]
43. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
44. Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma.
Zhang Y; Zou D; Yin J; Zhang L; Zhang X; Wang W; Zhang M; Zhou D; Zhang W
BMC Cancer; 2021 Feb; 21(1):183. PubMed ID: 33618687
[TBL] [Abstract][Full Text] [Related]
45. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
46. Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics.
Kim JH; An YJ; Kim TM; Kim JE; Park S; Choi SH
Cancer Med; 2023 Feb; 12(4):4679-4689. PubMed ID: 35941814
[TBL] [Abstract][Full Text] [Related]
47. Synergistically Bifunctional Paramagnetic Separation Enables Efficient Isolation of Urine Extracellular Vesicles and Downstream Phosphoproteomic Analysis.
Sun J; Han S; Ma L; Zhang H; Zhan Z; Aguilar HA; Zhang H; Xiao K; Gu Y; Gu Z; Tao WA
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3622-3630. PubMed ID: 33443402
[TBL] [Abstract][Full Text] [Related]
48. Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients.
Wang Y; Yang J; Wen Y
Biomed Pharmacother; 2022 Jan; 145():112392. PubMed ID: 34781140
[TBL] [Abstract][Full Text] [Related]
49. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons.
Corcoran C; Rebe K; van der Plas H; Myer L; Hardie DR
J Clin Virol; 2008 Aug; 42(4):433-6. PubMed ID: 18455472
[TBL] [Abstract][Full Text] [Related]
50. [Primary central nervous system lymphoma: a case report and evaluation of the diagnostic value of IL-10 level in the cerebrospinal fluid].
Mishima T; Tsuboi Y; Enomoto T; Higuchi MA; Tsugawa J; Yamada T; Tanaka T; Tsugu H; Hayashi H; Nabeshima K
Brain Nerve; 2012 Nov; 64(11):1347-51. PubMed ID: 23131747
[TBL] [Abstract][Full Text] [Related]
51. A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient.
DeRon N; Ahmed M; Lopez D; Alobaidi A
Cureus; 2022 Apr; 14(4):e23858. PubMed ID: 35530884
[TBL] [Abstract][Full Text] [Related]
52. Chemical Affinity-Based Isolation of Extracellular Vesicles from Biofluids for Proteomics and Phosphoproteomics Analysis.
Liu YK; Luo Z; Iliuk A; Tao WA
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37955372
[TBL] [Abstract][Full Text] [Related]
53. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC
Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057
[TBL] [Abstract][Full Text] [Related]
54. Application of cerebrospinal fluid free light chain in diagnosis of primary central nervous system lymphoma and monitoring of associated chemotherapy efficacy.
Hu Y; Xiang J; Luo X; Lu M; Xu D; Chen B; Guan M
Clin Chim Acta; 2022 Aug; 533():48-52. PubMed ID: 35716705
[TBL] [Abstract][Full Text] [Related]
55. CSF biomarkers in primary CNS lymphoma.
Nguyen-Them L; Alentorn A; Ahle G; Soussain C; Mathon B; Le Garff Tavernier M; Houillier C; Hoang-Xuan K
Rev Neurol (Paris); 2023 Mar; 179(3):141-149. PubMed ID: 36336490
[TBL] [Abstract][Full Text] [Related]
56. Spinal primary central nervous system lymphoma: Case report and literature review.
Feng L; Chen D; Zhou H; Shen C; Wang H; Sun X; Liang X; Chen L
J Clin Neurosci; 2018 Apr; 50():16-19. PubMed ID: 29429785
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Sasagawa Y; Akai T; Tachibana O; Iizuka H
J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
[TBL] [Abstract][Full Text] [Related]
58. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review.
Norrington M; Rathi N; Jenkinson MD; Mills SJ
J Clin Neurosci; 2021 Jul; 89():381-388. PubMed ID: 34083111
[TBL] [Abstract][Full Text] [Related]
59. Analysis of Cerebrospinal Fluid Extracellular Vesicles by Proximity Extension Assay: A Comparative Study of Four Isolation Kits.
Sjoqvist S; Otake K; Hirozane Y
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321992
[TBL] [Abstract][Full Text] [Related]
60. A rapid genotyping panel for detection of primary central nervous system lymphoma.
Gupta M; Burns EJ; Georgantas NZ; Thierauf J; Nayyar N; Gordon A; Jones SS; Pisapia M; Sun Y; Burns RP; Velarde J; Jordan JT; Frigault MJ; Nahed BV; Jones PS; Barker FG; Curry WT; Gupta R; Batchelor TT; Romero JM; Brastianos PK; Marble HD; Martinez-Lage M; Tateishi K; Lennerz JK; Dietrich J; Cahill DP; Carter BS; Shankar GM
Blood; 2021 Aug; 138(5):382-386. PubMed ID: 33735913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
